# Development of a Novel Biomarker for Liver Fibrosis

> **NCT02348814** · — · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 25 (actual)

## Conditions studied

- Liver Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02348814
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2019-01-26
- **Final completion:** 2019-02-26
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02348814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02348814, "Development of a Novel Biomarker for Liver Fibrosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02348814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*